282 related articles for article (PubMed ID: 32104349)
1. Formulation optimization of scutellarin-loaded HP-β-CD/chitosan nanoparticles using response surface methodology with Box-Behnken design.
Liu S; Ho PC
Asian J Pharm Sci; 2017 Jul; 12(4):378-385. PubMed ID: 32104349
[TBL] [Abstract][Full Text] [Related]
2. Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.
Soliman NM; Shakeel F; Haq N; Alanazi FK; Alshehri S; Bayomi M; Alenazi ASM; Alsarra IA
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889340
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia.
Liu S; Ho PC
J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432
[TBL] [Abstract][Full Text] [Related]
4. Formulation optimization of chelerythrine loaded O-carboxymethylchitosan microspheres using response surface methodology.
Li GY; Zhong M; Zhou ZD; Zhong YD; Ding P; Huang Y
Int J Biol Macromol; 2011 Dec; 49(5):970-8. PubMed ID: 21889529
[TBL] [Abstract][Full Text] [Related]
5. Response Surface Methodology for Statistical Optimization of Chitosan/Alginate Nanoparticles as a Vehicle for Recombinant Human Bone Morphogenetic Protein-2 Delivery.
Zohri M; Akbari Javar H; Gazori T; Khoshayand MR; Aghaee-Bakhtiari SH; Ghahremani MH
Int J Nanomedicine; 2020; 15():8345-8356. PubMed ID: 33154637
[TBL] [Abstract][Full Text] [Related]
6. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate loading in chitosan nanoparticles at a novel pH: Response surface modeling, optimization and characterization.
Hashad RA; Ishak RA; Geneidi AS; Mansour S
Int J Biol Macromol; 2016 Oct; 91():630-9. PubMed ID: 27283234
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology.
Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2016; 44(2):571-80. PubMed ID: 25363752
[TBL] [Abstract][Full Text] [Related]
10. [Optimization of Formulation and Process of Paclitaxel PEGylated Liposomes by Box-Behnken Response Surface Methodology].
Shi YJ; Zhang XF; Guo QT
Zhong Yao Cai; 2015 Dec; 38(12):2606-10. PubMed ID: 27352544
[TBL] [Abstract][Full Text] [Related]
11. Application of Box-Behnken design to prepare gentamicin-loaded calcium carbonate nanoparticles.
Maleki Dizaj S; Lotfipour F; Barzegar-Jalali M; Zarrintan MH; Adibkia K
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1475-81. PubMed ID: 25950955
[TBL] [Abstract][Full Text] [Related]
12. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Badran MM; Alanazi AE; Ibrahim MA; Alshora DH; Taha E; H Alomrani A
Polymers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835942
[TBL] [Abstract][Full Text] [Related]
15. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Adena SKR; Upadhyay M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2018 Mar; 44(3):493-501. PubMed ID: 29161920
[TBL] [Abstract][Full Text] [Related]
16. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
17. Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken design.
Wang F; Chen L; Jiang S; He J; Zhang X; Peng J; Xu Q; Li R
J Liposome Res; 2014 Sep; 24(3):171-81. PubMed ID: 24611687
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
[TBL] [Abstract][Full Text] [Related]
19. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
20. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
[Next] [New Search]